William Schuyler Jones, MD

Associate Professor of Medicine
Associate Professor in Population Health Sciences
Member of the Duke Clinical Research Institute
Campus mail 2400 Pratt Street, 7037, Durham, NC 27705
Phone (919) 668-8917
Email address schuyler.jones@duke.edu

I am an interventional cardiologist with a specific focus on the diagnosis and treatment of patients with cardiovascular disease. As a clinician, I see patients in the office and do coronary and peripheral vascular procedures (angiography and interventions) in the Duke Cardiac Catheterization Laboratory. I have served as the Medical Director of the cath lab at Duke since 2016. Alongside my partners in the cath lab, we collaborate with our cardiothoracic surgeons to hold Heart Team meetings each week, and we frequently are asked to address complex cardiovascular issues as a multidisciplinary team.

I also have a broad background in cardiovascular site-based research, multicenter clinical trials, clinical event classification, and observational analyses. I have helped to lead clinical trial efforts at the Duke Clinical Research Institute (DCRI) by designing and conducting studies evaluating new and existing treatments for patients with coronary artery disease and peripheral artery disease. My specific research interests include examining access to care and disparities in care for patients with peripheral artery disease and the design and conduct of pragmatic clinical trials in cardiovascular disease.

In Their Words

Education and Training

  • Fellow in Cardiology, Medicine, Duke University, 2004 - 2005
  • Medical Resident, Medicine, Duke University, 2001 - 2004
  • M.D., University of Arkansas, Little Rock, 2001

Publications

Weissler, E Hope, Dennis I. Narcisse, Jennifer A. Rymer, Ehrin J. Armstrong, Eric Secemsky, William A. Gray, Jihad A. Mustapha, et al. “Characteristics and Outcomes of Patients With Diabetes Mellitus Undergoing Peripheral Vascular Intervention for Infrainguinal Symptomatic Peripheral Artery Disease.” Vasc Endovascular Surg 55, no. 2 (February 2021): 124–34. https://doi.org/10.1177/1538574420968671.

PMID
33094679
Full Text

Varshney, Anubodh S., David E. Wang, Ankeet S. Bhatt, Alexander Blood, Musa A. Sharkawi, Hasan K. Siddiqi, Muthiah Vaduganathan, et al. “Characteristics of clinical trials evaluating cardiovascular therapies for Coronavirus Disease 2019 Registered on ClinicalTrials.gov: a cross sectional analysis.” American Heart Journal 232 (February 2021): 105–15. https://doi.org/10.1016/j.ahj.2020.10.065.

PMID
33121978
Full Text

Marquis-Gravel, Guillaume, Holly Robertson, W Schuyler Jones, Danielle Riley, Daniel E. Ford, David Crenshaw, Yvonne A. Joosten, Lindsey Rudov, Adrian F. Hernandez, and Rachel Hess. “Streamlining the institutional review board process in pragmatic randomized clinical trials: challenges and lessons learned from the Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) trial.” Trials 22, no. 1 (January 25, 2021): 90. https://doi.org/10.1186/s13063-021-05026-w.

PMID
33494785
Full Text

Galani, Jemi, Hillary Mulder, Frank W. Rockhold, E Hope Weissler, Iris Baumgartner, Jeffrey S. Berger, Juuso I. Blomster, et al. “Association of Chronic Obstructive Pulmonary Disease with Morbidity and Mortality in Patients with Peripheral Artery Disease: Insights from the EUCLID Trial.” Int J Chron Obstruct Pulmon Dis 16 (2021): 841–51. https://doi.org/10.2147/COPD.S292978.

PMID
33824584
Full Text

Ommen, Steve R., Seema Mital, Michael A. Burke, Sharlene M. Day, Anita Deswal, Perry Elliott, Lauren L. Evanovich, et al. “2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.” Circulation 142, no. 25 (December 22, 2020): e558–631. https://doi.org/10.1161/CIR.0000000000000937.

PMID
33215931
Full Text

Zeitouni, Michel, Robert M. Clare, Karen Chiswell, Jawan Abdulrahim, Nishant Shah, Neha P. Pagidipati, Svati H. Shah, Matthew T. Roe, Manesh R. Patel, and W Schuyler Jones. “Risk Factor Burden and Long-Term Prognosis of Patients With Premature Coronary Artery Disease.” J Am Heart Assoc 9, no. 24 (December 15, 2020): e017712. https://doi.org/10.1161/JAHA.120.017712.

PMID
33287625
Full Text

Patel, Manesh R., Sonia Anand, Rupert Bauersachs, Scott D. Berkowitz, Taylor Brackin, Sebastian Debus, Lloyd P. Haskell, et al. “Rivaroxaban Plus Aspirin versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From Voyager PAD.” In Circulation, 142:E488–89, 2020.

Scholars@Duke

Patel, Manesh R., Sonia Anand, Rupert Bauersachs, Scott D. Berkowitz, Taylor Brackin, Sebastian Debus, Lloyd P. Haskell, et al. “Rivaroxaban Plus Aspirin versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From Voyager PAD.” In Circulation, 142:E488–89, 2020.

Scholars@Duke

Weissler, E Hope, W Schuyler Jones, Ileana Desormais, Sebastian Debus, Lucia Mazzolai, Christine Espinola-Klein, Sigrid Nikol, et al. “Polyvascular disease: A narrative review of current evidence and a consideration of the role of antithrombotic therapy.” Atherosclerosis 315 (December 2020): 10–17. https://doi.org/10.1016/j.atherosclerosis.2020.11.001.

PMID
33190107
Full Text

Sullivan, Alexander E., Tara Holder, Tracy Truong, Cynthia L. Green, Olamiji Sofela, Talal Dahhan, Christopher B. Granger, W Schuyler Jones, and Manesh R. Patel. “Use of hospital resources in the care of patients with intermediate risk pulmonary embolism.” Eur Heart J Acute Cardiovasc Care, November 27, 2020, 2048872620921601. https://doi.org/10.1177/2048872620921601.

PMID
33242980
Full Text

Pages